No abstract

No abstract

The in situ X-ray absorption fine structure (XAFS) for the structural changes of Ag clusters produced in the cavity of luminescent zeolites by thermal treatment of Ag zeolite-A and Ag zeolite-X has been studied. The following procedures are compared: (i) samples are heated and cooled to room temperature under atmosphere (under air); (ii) samples are heated and cooled to room temperature in a vacuum and then exposed to air. It was confirmed that the Ag clusters were broken when the Ag zeolite was exposed to air for Ag zeolite-X, which complements our previous results for Ag12-A. It is suggested that the deformation of the Ag clusters plays an important role in the generation of a strong photoluminescence band, and Ag clusters may not be direct species producing the strong photoluminescence. The local structure of the Ag ions was found to be slightly different from that of the unheated species. The difference may originate from the formation and breakdown of Ag clusters in the zeolite cavity.

We examined the relation between the zeolite framework, Ag clusters, and properties of photoluminescence (PL) using in-situ infrared spectroscopy (IR) and X-ray absorption fine structure (XAFS). The Ag clusters are generated in the cavity of Ag-type zeolite-A that is cooled to room temperature after heating at 500°C for 24 hour under vacuum or in atmosphere. The Ag clusters in the zeolite cavity break down when air is introduced. According to the formation and breakdown of the Ag cluster, the infrared spectrum of the zeolite framework changed slightly. Then, this change was compensated by irradiation of the excitation light. Results suggest that the structural change in the zeolite induced by the formation and breakdown of the Ag clusters is a key point of the PL mechanism.

Background Recently, second-generation thyroglobulin (Tg) sandwich immunoassays have been used in clinical laboratories to measure the serum Tg levels, which is a tumor marker used to monitor postoperative patients with differentiated thyroid cancers. However, these immunoassays are often subject to Tg autoantibody (TgAb) interference. TgAb interference is inevitable for almost all Tg immunoassays, resulting in unreliable Tg measurement values of TgAb-positive samples. Methods To address TgAb interference, we have developed a novel immunoassay based on a fully automated chemiluminescent enzyme immunoassay system using the effective specimen-pretreatment process to inactivate TgAb in blood and evaluated its assay performance. Results The developed assay was traceable to BCR457 IRMM reference material with a limit of quantification of 0.03 ng/mL. The pretreatment process inactivated almost all TgAb in specimens and allowed accurate Tg measurements in TgAb-positive samples in which TgAb interference was observed using the immunoassays. Size-exclusion chromatography analysis of immunoreactive Tg molecule in a TgAb-positive serum verified disruption of the Tg–TgAb immune complex by the pretreatment process. Good correlation of Tg values in TgAb-negative specimens was observed between the new Tg immunoassay and the second-generation sandwich immunoassays. However, there were numerous discrepant samples on bias plots between the new Tg immunoassay and the second-generation sandwich immunoassays for TgAb-positive specimens. Conclusions This study indicates the new Tg immunoassay with the specimen-pretreatment process is both robust and free from interference by TgAb. Thus, this novel assay is superior to second-generation sandwich immunoassays and gives accurate Tg concentrations even for TgAb-positive cases.